IGF and mTOR pathway expression and in vitro effects of linsitinib and mTOR inhibitors in adrenocortical cancer

PURPOSE: The IGF and mTOR-pathways are considered as potential targets for therapy in patients with adrenocortical carcinoma (ACC). This study aims to describe the IGF pathway in ACC and to explore the response to the combined treatment with the IGF1R/IR inhibitor linsitinib, and mTOR inhibitors (si...

Descripción completa

Detalles Bibliográficos
Autores principales: De Martino, Maria Cristina, van Koetsveld, Peter M., Feelders, Richard A., de Herder, Wouter W., Dogan, Fadime, Janssen, Joseph A. M. J. L., Hofste op Bruinink, Davine, Pivonello, Claudia, Waaijers, A. Marlijn, Colao, Annamaria, de Krijger, Ronald R., Pivonello, Rosario, Hofland, Leo J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551351/
https://www.ncbi.nlm.nih.gov/pubmed/30838516
http://dx.doi.org/10.1007/s12020-019-01869-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551351/
https://www.ncbi.nlm.nih.gov/pubmed/30838516
http://dx.doi.org/10.1007/s12020-019-01869-1

Ejemplares similares